QualityStocksNewsBreaks Archives - Page 335 of 1535

ThursdayOct 05, 2023 12:14 pm

QualityStocksNewsBreaks – DoubleDown Interactive Co. Ltd. (NASDAQ: DDI) Announces ACS Donation, ‘Spin for a Cure’ Event

DoubleDown Interactive (NASDAQ: DDI), a leading developer and publisher of digital games on mobile and web-based platforms, today announced a planned donation of $10,000 to the American Cancer Society (“ACS”) in honor of Breast Cancer Awareness Month. According to the update, DoubleDown Casino, which is played daily by millions of fans worldwide on both desktop and mobile devices, will invite players to engage with and show support for the charitable donation by taking part in a play-to-enter giveaway on Oct. 11, 2023. The “Spin for a Cure” event offers players the chance to express their enthusiasm for helping the American…

ThursdayOct 05, 2023 12:05 pm

QualityStocksNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Reports Top-Line Results for Phase 2a Lomecel-B Clinical Trial

Longeveron (NASDAQ: LGVN; LGVNR), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, has released top-line results for its phase 2a trial of its investigational product Lomecel-B(TM). The study evaluated Lomecel-B for the treatment of mild Alzheimer’s disease. According to the report, the primary endpoint of safety was met across all study groups; in addition, the secondary endpoint of change from baseline to week 39 in Composite Alzheimer’s Disease Score (“CADS”) also demonstrated positive results. The report also noted that other doses demonstrated numerical…

ThursdayOct 05, 2023 11:29 am

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces $45.1M NINDS Grant to Support Expanded Access Protocol for CNM-Au8(R) in ALS

Clene (NASDAQ: CLNN), through its wholly owned subsidiary Clene Nanomedicine Inc. in collaboration with Columbia University and Synapticure, was awarded a four-year grant totaling $45.1 million from the National Institute of Neurological Disorders and Stroke (“NINDS”), a division of the National Institutes of Health (“NIH”). The grant is to support an Expanded Access Protocol (“EAP”) for the company’s investigational drug, CNM-Au8(R), in amyotrophic lateral sclerosis (“ALS”). Also referred to as Compassionate Use, an EAP is an FDA-regulated pathway that allows people with a serious and life-threatening disease to access an investigational drug that is not yet approved by the U.S.…

WednesdayOct 04, 2023 3:13 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Deploys K5 ASR, K1 Hemisphere for New Contracts in Southern California

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced two new contracts from a Los Angeles area shopping center and a medical clinic. The announcement reads, “The Knightscope K5 Autonomous Security Robot (‘ASR’) will be patrolling the interior of a large, cultural mall in the Los Angeles area. Shopping centers are places where people go to shop, dine, relax, browse or meet in a fun and safe atmosphere. Providing that safe environment reduces vacancies, mitigates risk, elevates property values and increases foot traffic. Knightscope ASRs have already successfully deterred substance abuse,…

WednesdayOct 04, 2023 2:26 pm

QualityStocksNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Issues Response to Short Seller Report

FingerMotion (NASDAQ: FNGR), a mobile services and data company, is responding to the Oct. 3, 2023, short seller report issued by Capybara Research, a short-selling research firm. According to the statement, FingerMotion management reviewed the report and believe that the report contains errors, unsupported speculations and inaccurate interpretations of events; management and the company’s board of directors are planning further review and examination of allegations and misinformation contained in the report. The company “will take whatever necessary and appropriate actions may be required to protect the interest of its shareholders,” the announcement stated. “The company is already in the process…

WednesdayOct 04, 2023 1:58 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Unveil Encouraging Data on REQORSA(R) for Lung Cancer Treatment at 2023 AACR-NIH-EORTC Conference

Genprex (NASDAQ: GNPX) is at the forefront of pioneering cancer treatments, and it’s making waves with remarkable advancements in lung cancer therapy. The company will be sharing compelling clinical and preclinical data at the prestigious 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, taking place October 11-15 at the Hynes Convention Center in Boston. The Acclaim-1 Phase 1 study results have demonstrated the safety and efficacy of REQORSA(R) in combination with Tagrisso(R), bringing hope to patients with late-stage NSCLC. Moreover, preclinical studies have highlighted REQORSA(R)'s potential in combination with a checkpoint inhibitor to combat chemotherapy-resistant small cell lung…

WednesdayOct 04, 2023 12:27 pm

QualityStocksNewsBreaks — Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Announces Selection as Autotech CTA Silicon Valley Program Participant

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), a leading developer of rare earth element processing technology, has been selected by Global Affairs Canada to attend the Autotech CTA Fall 2023 Program; the program is slated for Oct. 10–12, 2023, in San Jose, California. Organized by the Government of Canada's Trade Commissioner Service in Palo Alto and the Province of Ontario Trade & Investment Office in San Francisco, the event is designed to provide companies that participate in the program with access to potential U.S. customers, strategic partners and investors through presentations and one-on-one meetings; the event also is an ideal…

WednesdayOct 04, 2023 11:47 am

QualityStocksNewsBreaks – NextPlat Corp. (NASDAQ: NXPL) to Present at Upcoming Dawson James Conference

NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, today announced that it will present at the 8th Annual Dawson James Conference taking place at the Wyndam Grand Jupiter at Harbourside Place in Jupiter, Florida, on Thursday, Oct. 12, 2023. NextPlat Corp’s executive chairman and CEO Charles M. Fernandez will deliver the company’s presentation and conduct in-person, one-on-one meetings throughout the conference. Fernandez’s presentation is slated to begin at 11 a.m. ET in Preserve Ballroom C. To view the full press release, visit https://ibn.fm/9aYVp About NextPlat Corp. NextPlat is a global e-commerce platform company created to capitalize on multiple high-growth sectors…

WednesdayOct 04, 2023 11:36 am

QualityStocksNewsBreaks – Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Provides Update Horizontal Development Production

Prospera Energy (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B), a public oil and gas exploration, exploitation and development company focusing on conventional oil and gas reservoirs in western Canada, is reporting that two of its five horizontal wells have begun production over the past week. According to the announcement, each well produced 125 bpd with less than 1% water cut. The company strategically brought these new horizontal wells into production at a low pump efficiency of about 30% in order to accommodate the heavier viscous oil and achieve steady flow, designed to peak over the next few months. The company noted…

WednesdayOct 04, 2023 10:21 am

QualityStocksNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Participation at CPHI Barcelona 2023, Other Upcoming Events

Scinai Immunotherapeutics (NASDAQ: SCNI) today announced that it will showcase its CDMO services at CPHI Barcelona, one of the international pharmaceutical industry’s premier trade shows, taking place Oct. 24 to 26. Scinai’s CDMO offers upstream and downstream process development and scale-up for protein-based drugs, analytical method development, and cGMP manufacturing including aseptic filling to biopharmaceutical and biotech clients. According to the announcement, several members of Scinai’s executive leadership team will be available to meet with potential partners and clients of the company’s end-to-end biologics CDMO service. Interested parties may request one-to-one meetings through the CPHI partnering platform, accessible to participants…

Site Search

Company Search

Category: QualityStocksNewsBreaks